Associate Professor of the Department of Infectious Diseases Sergei Voznesensky commented on the statement by the director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg on the advantage of a nasal vaccine against coronavirus over standard vaccination.
We will remind, earlier Gunzburg suggested to citizens vaccinated against coronavirus, it makes sense to do an additional nasal vaccination. In this case, they will cease to be carriers of the infection.
However, Voznesensky urged not to rush to conclusions.
“Only after the publication of the results of the study with an understandable time frame and on various population groups, it will be possible to talk about the effectiveness of the nasal vaccine,” the scientist emphasized.